JumpStart Invests $250,000 in Sequencing Data Analysis Startup GenomOncology | GenomeWeb

NEW YORK (GenomeWeb News) – JumpStart, a non-profit venture development organization based in Cleveland, said on Tuesday it is committing $250,000 to GenomOncology, an Ohio-based startup developing tools and software for analyzing genomic sequencing data for clinical applications.

GenomOncology's technology is designed to detect and analyze genetic mutations, and the Westlake, Ohio-based company plans to be a one-stop shop for analyzing large volumes of data and turning it into useful information for clinicians, said JumpStart.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.